{
  "pmcid": "115849",
  "config": {
    "model": "gpt",
    "strategy": "zero-shot"
  },
  "usage": {
    "input": 15687,
    "output": 3104
  },
  "raw_text": "{\"extractions\":[{\"outcome\":\"Discontinuation due to lack of efficacy\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"naproxen 500 mg twice daily\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":181,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"patients discontinued due to lack of efficacy\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"placebo\",\"outcome_type\":\"binary\",\"intervention_events\":44,\"intervention_group_size\":353,\"comparator_events\":90,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"patients discontinued due to lack of efficacy\",\"intervention\":\"naproxen 500 mg twice daily\",\"comparator\":\"placebo\",\"outcome_type\":\"binary\",\"intervention_events\":19,\"intervention_group_size\":181,\"comparator_events\":90,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Patient global assessment of disease activity\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"investigator global assessment of disease activity\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Tender joint count\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Swollen joint count\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Patient global assessment of pain\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Health Assessment Questionnaire disability\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Serum C-reactive protein\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"ACR20 responder criteria\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Discontinuation due to lack of efficacy\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Patient global assessment of disease activity\",\"intervention\":\"naproxen 500 mg twice daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":181,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"investigator global assessment of disease activity\",\"intervention\":\"naproxen 500 mg twice daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":181,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Tender joint count\",\"intervention\":\"naproxen 500 mg twice daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":181,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Swollen joint count\",\"intervention\":\"naproxen 500 mg twice daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":181,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Patient global assessment of pain\",\"intervention\":\"naproxen 500 mg twice daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":181,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Health Assessment Questionnaire disability\",\"intervention\":\"naproxen 500 mg twice daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":181,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Serum C-reactive protein\",\"intervention\":\"naproxen 500 mg twice daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":181,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"ACR20 responder criteria\",\"intervention\":\"naproxen 500 mg twice daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":181,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Discontinuation due to lack of efficacy\",\"intervention\":\"naproxen 500 mg twice daily\",\"comparator\":\"placebo\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":181,\"comparator_events\":null,\"comparator_group_size\":357,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Patient global assessment of disease activity\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"naproxen 500 mg twice daily\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":181,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"investigator global assessment of disease activity\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"naproxen 500 mg twice daily\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":181,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Tender joint count\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"naproxen 500 mg twice daily\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":181,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Swollen joint count\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"naproxen 500 mg twice daily\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":181,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Patient global assessment of pain\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"naproxen 500 mg twice daily\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":181,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Health Assessment Questionnaire disability\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"naproxen 500 mg twice daily\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":181,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"Serum C-reactive protein\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"naproxen 500 mg twice daily\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":181,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null},{\"outcome\":\"ACR20 responder criteria\",\"intervention\":\"etoricoxib 90 mg once daily\",\"comparator\":\"naproxen 500 mg twice daily\",\"outcome_type\":\"continuous\",\"intervention_events\":null,\"intervention_group_size\":353,\"comparator_events\":null,\"comparator_group_size\":181,\"intervention_mean\":null,\"intervention_standard_deviation\":null,\"comparator_mean\":null,\"comparator_standard_deviation\":null}]}",
  "extraction": [
    {
      "outcome": "Discontinuation due to lack of efficacy",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "naproxen 500 mg twice daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 181,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "patients discontinued due to lack of efficacy",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "placebo",
      "outcome_type": "binary",
      "intervention_events": 44,
      "intervention_group_size": 353,
      "comparator_events": 90,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "patients discontinued due to lack of efficacy",
      "intervention": "naproxen 500 mg twice daily",
      "comparator": "placebo",
      "outcome_type": "binary",
      "intervention_events": 19,
      "intervention_group_size": 181,
      "comparator_events": 90,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Patient global assessment of disease activity",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "investigator global assessment of disease activity",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Tender joint count",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Swollen joint count",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Patient global assessment of pain",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Health Assessment Questionnaire disability",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Serum C-reactive protein",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "ACR20 responder criteria",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Discontinuation due to lack of efficacy",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Patient global assessment of disease activity",
      "intervention": "naproxen 500 mg twice daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 181,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "investigator global assessment of disease activity",
      "intervention": "naproxen 500 mg twice daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 181,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Tender joint count",
      "intervention": "naproxen 500 mg twice daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 181,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Swollen joint count",
      "intervention": "naproxen 500 mg twice daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 181,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Patient global assessment of pain",
      "intervention": "naproxen 500 mg twice daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 181,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Health Assessment Questionnaire disability",
      "intervention": "naproxen 500 mg twice daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 181,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Serum C-reactive protein",
      "intervention": "naproxen 500 mg twice daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 181,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "ACR20 responder criteria",
      "intervention": "naproxen 500 mg twice daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 181,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Discontinuation due to lack of efficacy",
      "intervention": "naproxen 500 mg twice daily",
      "comparator": "placebo",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 181,
      "comparator_events": null,
      "comparator_group_size": 357,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Patient global assessment of disease activity",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "naproxen 500 mg twice daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 181,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "investigator global assessment of disease activity",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "naproxen 500 mg twice daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 181,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Tender joint count",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "naproxen 500 mg twice daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 181,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Swollen joint count",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "naproxen 500 mg twice daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 181,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Patient global assessment of pain",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "naproxen 500 mg twice daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 181,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Health Assessment Questionnaire disability",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "naproxen 500 mg twice daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 181,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "Serum C-reactive protein",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "naproxen 500 mg twice daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 181,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    },
    {
      "outcome": "ACR20 responder criteria",
      "intervention": "etoricoxib 90 mg once daily",
      "comparator": "naproxen 500 mg twice daily",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 353,
      "comparator_events": null,
      "comparator_group_size": 181,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "115849"
    }
  ]
}